In 2026, sustainability is more than a ‘buzzword’. It is a core strategic expectation essential for longevity and a robust value chain. Looking beyond the ...
Advanced therapies are reshaping the treatment landscape, offering curative potential for conditions once managed only symptomatically. Gene therapies, gene modified cell therapies, mRNA medicines, and ...
In recent years, growing concerns around the sustainability and environmental impact of conventional protein sources, combined with the need to secure sufficient protein supply to ...
The pharmaceutical industry is increasingly looking to meet the opportunities and needs of a broad agenda on sustainability, from the more efficient use of materials ...
Sustainability is multi-faceted. Beyond direct environmental impacts such as carbon emissions from manufacturing, a company’s sustainable practices should also account for indirect impacts across the ...
Advanced therapies are reshaping the treatment landscape, offering curative potential for conditions once managed only symptomatically. Gene therapies, gene modified cell therapies, mRNA medicines, and DNA based vaccines ...
In recent years, growing concerns around the sustainability and environmental impact of conventional protein sources, combined with the need to secure sufficient protein supply to meet the increasing ...
The pharmaceutical industry is increasingly looking to meet the opportunities and needs of a broad agenda on sustainability, from the more efficient use of materials and reducing energy ...
Sustainability is multi-faceted. Beyond direct environmental impacts such as carbon emissions from manufacturing, a company’s sustainable practices should also account for indirect impacts across the entire product lifecycle. ...
The environmental impact of the pharmaceutical industry is hard to quantify, but it has been suggested Pharma may be responsible for 300 million tons of plastic waste each ...
The next few years will see substantial changes for pressurised metered-dose inhalers (pMDIs). As a result of emerging regulations such as the European Union’s F-Gas legislation and the ...
With more than 70 years’ experience in medical devices, Owen Mumford Pharmaceutical Services is a division of Owen Mumford, with the Head Office located in ...
